Crescent BiopharmaCBIO
13F holders, Q1 2026 (March 31)60holders +4
14new positions
11sold out
3famous investors
$18.37avg. 13F price*
At the end of Q1 2026, 60 institutions reported holding Crescent Biopharma Inc. (CBIO) in their 13F filings, up 4 from Q4 2025. 14 opened new positions and 11 sold out. The largest holders were FMR LLC ($75.9M), BVF Inc. ($50.5M) and Fairmount Funds Management LLC ($50.5M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Crescent Biopharma Inc.
- CUSIP
- G2545C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $11.7M |
| Exits | 11 | $15.8M |
All 13F filers, Q4 2025 → Q1 2026: 3,445,474 shares bought and 2,337,919 shares sold, net +1,107,555 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 60 holders
| FMR LLC | 0.00% | No change | 4,133,514 | $75.9M |
| BVF Inc. | 1.61% | No change | 2,748,763 | $50.5M |
| Fairmount Funds Management LLC | 3.65% | No change | 2,747,866 | $50.5M |
| Venrock Adviser, LLC | 1.46% | No change | 2,133,576 | $39.2M |
| FCPM III Services B.V. | 4.27% | No change | 1,677,852 | $30.8M |
| Balyasny Asset Management L.P. | 0.06% | Add +1251.7% | 1,510,033 | $27.7M |
| Vestal Point Capital, LP | 0.77% | No change | 1,500,000 | $27.6M |
| Opaleye Management Inc. | 3.18% | Add +11.4% | 1,312,615 | $24.1M |
| Tang Capital Management LLC | 1.08% | Add +33.0% | 1,160,000 | $21.3M |
| Vanguard Capital Management LLC | 0.00% | — | 801,395 | $14.7M |
| Logos Global Management LP | 0.46% | Reduce -19.6% | 482,500 | $8.9M |
| Deep Track Capital, LP | 0.17% | No change | 453,686 | $8.3M |
| NEXTBio Capital Management LP | 3.18% | No change | 372,856 | $6.8M |
| RTW Investments, LP | 0.07% | No change | 372,856 | $6.8M |
| Millennium Management | 0.00% | Add +422.9% | 323,553 | $5.9M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -10.2% | 303,551 | $5.6M |
| Point72 Asset Management | 0.01% | No change | 300,000 | $5.5M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 264,000 | $4.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +805.0% | 228,475 | $4.2M |
| Susquehanna International Group, LLP | 0.01% | Add +274.5% | 213,635 | $3.9M |
| Perceptive Advisors LLC | 0.08% | Reduce -54.4% | 206,942 | $3.8M |
| Marshall Wace, LLP | 0.00% | Add +819.9% | 200,780 | $3.7M |
| Exome Asset Management LLC | 1.66% | New | 153,191 | $2.8M |
| Jennison Associates LLC | 0.00% | New | 152,974 | $2.8M |
| Silverarc Capital Management, LLC | 0.28% | New | 130,500 | $2.4M |
| Two Sigma Investments, LP | 0.00% | Reduce -7.5% | 115,828 | $2.1M |
| BlackRock, Inc. | 0.00% | Add +6.0% | 115,725 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +14.4% | 104,221 | $1.9M |
| Hudson Bay Capital Management LP | 0.01% | New | 88,867 | $1.6M |
| Stonepine Capital Management, LLC | 1.37% | Reduce -3.1% | 85,000 | $1.6M |
| UBS Group AG | 0.00% | Add +1060.8% | 82,706 | $1.5M |
| Burkehill Global Management, LP | 0.07% | No change | 74,000 | $1.4M |
| Woodline Partners LP | 0.01% | No change | 74,000 | $1.4M |
| ADAR1 Capital Management, LLC | 0.06% | Reduce -91.7% | 50,273 | $924K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 49,423 | $908K |
| State Street Corp. | 0.00% | Add +49.0% | 39,067 | $718K |
| JPMorgan Chase & Co. | 0.00% | Add +75.7% | 41,004 | $681K |
| Barclays PLC | 0.00% | New | 30,189 | $555K |
| Bank of America Corp. | 0.00% | Add +425.3% | 29,277 | $538K |
| Moore Capital Management, LP | 0.02% | No change | 25,000 | $459K |
| Lighthouse Investment Partners, LLC | 0.02% | New | 25,000 | $459K |
| Manufacturers Life Insurance Company, The | 0.00% | No change | 24,903 | $457K |
| Renaissance Technologies | 0.00% | Reduce -48.0% | 24,262 | $446K |
| Citigroup Inc. | 0.00% | Add +3137.4% | 20,169 | $371K |
| Brevan Howard Capital Management LP | 0.00% | New | 19,530 | $359K |
| Morgan Stanley | 0.00% | Reduce -32.5% | 18,577 | $341K |
| OMERS ADMINISTRATION Corp | 0.00% | Add +53.5% | 17,800 | $327K |
| Northern Trust Corp. | 0.00% | No change | 17,229 | $316K |
| BNP Paribas Financial Markets | 0.00% | Add +337.8% | 15,694 | $288K |
| Algert Global LLC | 0.00% | New | 13,806 | $254K |
| Verdad Advisers, LP | 0.26% | New | 12,748 | $234K |
| Cannon Global Investment Management, LLC | 0.46% | New | 10,200 | $187K |
| Vanguard Global Advisers, LLC | 0.00% | — | 3,469 | $64K |
| Parallel Advisors, LLC | 0.00% | New | 264 | $5K |
| Allworth Financial LP | 0.00% | New | 161 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 68 | $1K |
| Royal Bank of Canada | 0.00% | Add +155.0% | 51 | $1K |
| Fortitude Family Office, LLC | 0.00% | New | 40 | $735 |
| Osaic Holdings, Inc. | 0.00% | No change | 26 | $477 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 4 | $73 |
"% of holder's portfolio" is CBIO's weight in each manager's 13F, not the share of Crescent Biopharma Inc. the manager owns.